Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
D000328:Adult; D000568:Amenorrhea / Q000150:complications / Q000503:physiopathology*; D004298:Dopamine / Q000502:physiology; D004967:Estrogens / Q000097:blood*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006801:Humans; D007006:Hypogonadism / Q000150:complications / Q000503:physiopathology*; D007031:Hypothalamus / Q000503:physiopathology*; D007700:Kinetics; D007986:Luteinizing Hormone / Q000097:blood*; D008787:Metoclopramide; D009270:Naloxone; D011388:Prolactin / Q000097:blood*; D011957:Receptors, Opioid / Q000502:physiology
D004967:Estrogens; D011957:Receptors, Opioid; D009270:Naloxone; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D008787:Metoclopramide; D004298:Dopamine